Literature DB >> 8436296

The extremely conserved amino terminus of RAD6 ubiquitin-conjugating enzyme is essential for amino-end rule-dependent protein degradation.

J F Watkins1, P Sung, S Prakash, L Prakash.   

Abstract

The RAD6 gene of Saccharomyces cerevisiae encodes a ubiquitin-conjugating enzyme that is required for DNA repair, damage-induced mutagenesis, and sporulation. In addition, RAD6 mediates the multiubiquitination and degradation of amino-end rule protein substrates. The structure and function of RAD6 have been remarkably conserved during eukaryotic evolution. Here, we examine the role of the extremely conserved amino terminus, which has remained almost invariant among RAD6 homologs from yeast to human. We show that RAD6 is concentrated in the nucleus and that the amino-terminal deletion mutation, rad6 delta 1-9, does not alter the location of the protein. The amino-terminal domain, however, is essential for the multiubiquitination and degradation of amino-end rule substrates. In the rad6 delta 1-9 mutant, beta-galactosidase proteins bearing destabilizing amino-terminal residues become long lived, and purified rad6 delta 1-9 protein is ineffective in ubiquitin-protein ligase (E3)-dependent protein degradation in the proteolytic system derived from rabbit reticulocytes. The amino terminus is required for physical interaction of RAD6 with the yeast UBR1-encoded E3 enzyme, as the rad6 delta 1-9 protein is defective in this respect. The rad6 delta 1-9 mutant is defective in sporulation, shows reduced efficiency of DNA repair, but is proficient in UV mutagenesis. E3-dependent protein degradation by RAD6 could be essential for sporulation and could affect the efficiency of DNA repair.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436296     DOI: 10.1101/gad.7.2.250

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  25 in total

1.  Suppression of genetic defects within the RAD6 pathway by srs2 is specific for error-free post-replication repair but not for damage-induced mutagenesis.

Authors:  Stacey Broomfield; Wei Xiao
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

Review 2.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

3.  The ubiquitin-conjugating enzyme Rad6 (Ubc2) is required for silencing in Saccharomyces cerevisiae.

Authors:  H Huang; A Kahana; D E Gottschling; L Prakash; S W Liebman
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

Review 4.  Formation and repair of interstrand cross-links in DNA.

Authors:  David M Noll; Tracey McGregor Mason; Paul S Miller
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

5.  E2 ligase dRad6 regulates DMP53 turnover in Drosophila.

Authors:  Su Chen; Hui-Min Wei; Wen-Wen Lv; Da-Liang Wang; Fang-Lin Sun
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

6.  MMS2, encoding a ubiquitin-conjugating-enzyme-like protein, is a member of the yeast error-free postreplication repair pathway.

Authors:  S Broomfield; B L Chow; W Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Dissection of the functions of the Saccharomyces cerevisiae RAD6 postreplicative repair group in mutagenesis and UV sensitivity.

Authors:  P Cejka; V Vondrejs; Z Storchová
Journal:  Genetics       Date:  2001-11       Impact factor: 4.562

8.  The products of the yeast MMS2 and two human homologs (hMMS2 and CROC-1) define a structurally and functionally conserved Ubc-like protein family.

Authors:  W Xiao; S L Lin; S Broomfield; B L Chow; Y F Wei
Journal:  Nucleic Acids Res       Date:  1998-09-01       Impact factor: 16.971

9.  Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination.

Authors:  Kenji Watanabe; Satoshi Tateishi; Michio Kawasuji; Toshiki Tsurimoto; Hirokazu Inoue; Masaru Yamaizumi
Journal:  EMBO J       Date:  2004-09-09       Impact factor: 11.598

10.  Novel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization.

Authors:  Matthew A Sanders; Ghali Brahemi; Pratima Nangia-Makker; Vitaly Balan; Matteo Morelli; Hend Kothayer; Andrew D Westwell; Malathy P V Shekhar
Journal:  Mol Cancer Ther       Date:  2013-01-21       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.